RPRX

Royalty Pharma plc

Healthcare
Medical - Pharmaceuticals
$28.44B market cap

Forecast run · Oct 29, 2026Upside rank 2152 of 3,186

Model Signal

ForecastQ Daily Probabilities

17.5%

78.4%

5.1%

Analyst Consensus

Recommendation2.00/5 Buy

Last price$63.86

Price target$66.50

Implied move+4.1%

Analysts11

ForecastQ Portfolios

RPRX is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.